1. Home
  2. RDHL vs AGMH Comparison

RDHL vs AGMH Comparison

Compare RDHL & AGMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • AGMH
  • Stock Information
  • Founded
  • RDHL 2009
  • AGMH 2015
  • Country
  • RDHL Israel
  • AGMH Hong Kong
  • Employees
  • RDHL N/A
  • AGMH N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • AGMH EDP Services
  • Sector
  • RDHL Health Care
  • AGMH Technology
  • Exchange
  • RDHL Nasdaq
  • AGMH Nasdaq
  • Market Cap
  • RDHL 3.9M
  • AGMH 3.5M
  • IPO Year
  • RDHL N/A
  • AGMH 2018
  • Fundamental
  • Price
  • RDHL $1.23
  • AGMH $2.23
  • Analyst Decision
  • RDHL
  • AGMH
  • Analyst Count
  • RDHL 0
  • AGMH 0
  • Target Price
  • RDHL N/A
  • AGMH N/A
  • AVG Volume (30 Days)
  • RDHL 1.4M
  • AGMH 252.4K
  • Earning Date
  • RDHL 08-28-2025
  • AGMH 08-12-2025
  • Dividend Yield
  • RDHL N/A
  • AGMH N/A
  • EPS Growth
  • RDHL N/A
  • AGMH N/A
  • EPS
  • RDHL N/A
  • AGMH 6.43
  • Revenue
  • RDHL $8,042,999.00
  • AGMH $32,044,575.00
  • Revenue This Year
  • RDHL $381.91
  • AGMH N/A
  • Revenue Next Year
  • RDHL N/A
  • AGMH N/A
  • P/E Ratio
  • RDHL N/A
  • AGMH $0.31
  • Revenue Growth
  • RDHL 23.17
  • AGMH N/A
  • 52 Week Low
  • RDHL $1.17
  • AGMH $1.09
  • 52 Week High
  • RDHL $15.34
  • AGMH $109.50
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 33.65
  • AGMH 41.31
  • Support Level
  • RDHL $1.17
  • AGMH $1.91
  • Resistance Level
  • RDHL $3.31
  • AGMH $2.59
  • Average True Range (ATR)
  • RDHL 0.31
  • AGMH 0.24
  • MACD
  • RDHL -0.09
  • AGMH -0.03
  • Stochastic Oscillator
  • RDHL 2.80
  • AGMH 26.12

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

About AGMH AGM Group Holdings Inc.

AGM Group Holdings Inc is an investment holding company. The company focuses on blockchain-oriented ASIC chip design; high-end crypto miner production and fintech technology software service. It generates maximum revenue from the sale of cryptocurrency mining machines and standardized computing equipment.

Share on Social Networks: